Long-term efficacy of tenofovir alafenamide in HBeAg-positive and -negative chronic hepatitis B patients treated for up to 8 years in 2 phase 3 studies

被引：0

作者：

Buti, Maria ^{[1
,2
]}

Agarwal, Kosh ^{[3
]}

Chan, Henry Ly ^{[4
]}

Seto, Wai-Kay ^{[5
,6
]}

Lim, Young-Suk ^{[7
]}

Brunetto, Maurizia ^{[8
]}

Chuang, Wan-Long ^{[9
]}

Janssen, Harry ^{[10
,11
]}

Fung, Scott ^{[12
]}

Izumi, Namiki ^{[13
]}

Jablkowski, Maciej ^{[14
]}

Abramov, Frida ^{[15
]}

Wang, Hongyuan ^{[15
]}

Yee, Leland ^{[15
]}

Mateo, Roberto ^{[15
]}

Flaherty, John F. ^{[15
]}

Pan, Calvin ^{[16
]}

Shalimar ^{[17
]}

Marcellin, Patrick ^{[18
]}

Gane, Edward J. ^{[19
]}

机构：

[1] Hosp Univ Vall dHebron, Barcelona, Spain

[2] CIBEREHD Inst Carlos III, Madrid, Spain

[3] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England

[4] Chinese Univ Hong Kong, 9F Union Hosp, HMA Off, Tai Wai, Hong Kong, Peoples R China

[5] Univ Hong Kong, Dept Med, Pok Fu Lam, Hong Kong, Peoples R China

[6] Univ Hong Kong, Sch Clin Med, Pok Fu Lam, Hong Kong, Peoples R China

[7] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea

[8] Azienda Osped Univ Pisana, Pisa, Italy

[9] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[10] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[11] Erasmus MC, Rotterdam, Netherlands

[12] Univ Toronto, Dept Med, Toronto, ON, Canada

[13] Japanese Red Cross Musashino Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan

[14] Med Univ Lodz, Lodz, Poland

[15] Gilead Sci Inc, Foster City, CA USA

[16] New York Univ, NYU Langone Hlth, Grossman Sch Med, New York, NY USA

[17] All India Inst Med Sci, New Delhi, India

[18] Hop Beaujon, Hepatol Dept, Clichy, France

[19] Auckland Clin Studies, Symonds St, Auckland, New Zealand

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OS-067

引用

页码：S57 / S57

页数：1

共 50 条

[41] LONG TERM (4 YEAR) EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-POSITIVE PATIENTS (HBEAG plus ) WITH CHRONIC HEPATITIS B (STUDY 103): PRELIMINARY ANALYSIS
Heathcote, E. Jenny
Gane, Edward J.
deMan, Robert A.
Chan, Sing
George, Jacob
Tsai, Naoky C. S. C.
Marcellin, Patrick
Snow-Lampart, Andrea
Coombs, Derek H.
Mondou, Elsa
Anderson, Jane
HEPATOLOGY, 2010, 52 (04) : 556A - 557A
[42] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-NEGATIVE, CHRONIC HEPATITIS B PATIENTS: A GLOBAL PHASE 3 STUDY
Brunetto, Maurizia Rossana
Lim, Young-Suk
Gane, Edward
Seto, Wai-Kay
Osipenko, Marina
Ahn, Sang Hoon
Janssen, Harry L.
Shukla, Akash
Chuang, Wan-Long
Trinh, Huy N.
Celen, Mustafa
Flaherty, John F.
Chan, Alain
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Subramanian, Mani
Pan, Calvin Q.
Izumi, Namiki
Marcellin, Patrick
Chan, Henry L.
Buti, Maria
GASTROENTEROLOGY, 2017, 152 (05) : S1086 - S1086
[43] THREE YEARS OF TENOFOVIR DISOPROXIL (TDF) TREATMENT IN HBEAG-POSITIVE PATIENTS (HBEAG plus ) WITH CHRONIC HEPATITIS B (STUDY 103), PRELIMINARY ANALYSIS
Heathcote, E. Jenny
Gane, Edward J.
De Man, Robert A.
Lee, Samuel S.
Flisiak, Robert
Manns, Michael P.
Tchernev, Konstantin G.
Kurdas, Ayse Oya Oevuenc
Shiffman, Mitchell L.
Marcellin, Patrick
Sorbel, Jeff
Anderson, Jane
Mondou, Elsa
Rousseau, Franck
HEPATOLOGY, 2009, 50 (04) : 533A - 534A
[44] Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
He, D.
Guo, S.
Zhu, P.
Tao, S.
Li, M.
Huang, H.
Wang, J.
Wang, Y.
Ding, M.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O687 - O693
[45] Hepatitis B virus relapse after discontinuation of long-term treatment with tenofovir in chronic HBeAg-negative patients
Buti, Maria
Homs, Maria
Casillas, Rosario
Tabernero, David
Gregori, Josep
Gonzalez, Carolina
Riveiro-Barciela, Mar
Teresa Salcedo, Maria
Blasi, Maria
Nieto, Leonardo
Rodriguez-Frias, Francisco
Esteban, Rafael
HEPATOLOGY, 2014, 60 : 1032A - 1032A
[46] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Hadziyannis, Stephanos J.
Tassopoulos, Nicolaos C.
Heathcote, E. Jenny
Chang, Ting-Tsung
Kitis, George
Rizzetto, Mario
Marcellin, Patrick
Lik, Seng Gee
Goodman, Zachary
Ma, Jia
Brosgart, Carol L.
Eorroto-Esoda, Katyna
Arterburn, Sarah
Chuck, Steven L.
GASTROENTEROLOGY, 2006, 131 (06) : 1743 - 1751
[47] High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
Moucari, Rami
Korevaar, Anneke
Lada, Olivier
Martinot-Peignoux, Michelle
Boyer, Nathalie
Mackiewicz, Vincent
Dauvergne, Agnes
Cardoso, Ana C.
Asselah, Tarik
Nicolas-Chanoine, Marie-Helene
Vidaud, Michel
Valla, Dominique
Bedossa, Pierre
Marcellin, Patrick
JOURNAL OF HEPATOLOGY, 2009, 50 (06) : 1084 - 1092
[48] Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive HBeAg-positive patients with chronic hepatitis B A large, multicentre, randomized controlled trials
Cai, Dachuan
Pan, Chen
Yu, Weihua
Dang, Shuangsuo
Li, Jia
Wu, Shanming
Jiang, Nan
Wang, Maorong
Zhang, Zhaohua
Lin, Feng
Xin, Shaojie
Yang, Yongfeng
Shen, Baoshen
Ren, Hong
MEDICINE, 2019, 98 (01)
[49] THERAPEUTIC EFFICACY OF INTERLEUKIN-2 IN HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS
KUROKI, T
TAKEDA, T
NISHIGUCHI, S
NAKAJIMA, S
SHIOMI, S
SAITO, S
MIZOGUCHI, Y
KOBAYASHI, K
GASTROENTEROLOGY, 1987, 92 (05) : 1746 - 1746
[50] Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years
Maria Buti
Scott Fung
Edward Gane
Nezam H. Afdhal
Robert Flisiak
Selim Gurel
John F. Flaherty
Eduardo B. Martins
Leland J. Yee
Phillip Dinh
Jeffrey D. Bornstein
G. Mani Subramanian
Harry L. A. Janssen
Jacob George
Patrick Marcellin
Hepatology International, 2015, 9 : 243 - 250

← 1 2 3 4 5 →